Caris Life Sciences (CAI) Enterprise Value (2024 - 2026)

Caris Life Sciences' Enterprise Value history runs 3 years deep, the most recent figure standing at -$823.5 million for Q1 2026.

• In Q1 2026, Enterprise Value changed N/A year-over-year to -$823.5 million; the TTM figure through Mar 2026 stood at -$823.5 million (changed N/A YoY), while the FY2025 annual figure was -$800.1 million, down 1095.35% from the prior year.
• Enterprise Value was -$823.5 million for Q1 2026 at Caris Life Sciences, down from -$800.1 million in the prior quarter.
• In the past five years, Enterprise Value ranged from a high of -$66.9 million in Q4 2024 to a low of -$823.5 million in Q1 2026.
• Historically, Enterprise Value has averaged -$634.0 million across 3 years, with a median of -$757.0 million in 2025.
• Biggest YoY gain for Enterprise Value was 1095.35% in 2025; the steepest drop was 1095.35% in 2025.
• A 3-year view of Enterprise Value shows it stood at -$66.9 million in 2024, then tumbled by 1095.35% to -$800.1 million in 2025, then slipped by 2.92% to -$823.5 million in 2026.
• The last three Enterprise Value figures came in at -$823.5 million (Q1 2026), -$800.1 million (Q4 2025), and -$757.0 million (Q3 2025), per Business Quant data.